Singapore markets closed

Johnson & Johnson (JNJ)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
165.00+4.88 (+3.05%)
As of 11:55AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close160.12
Bid164.99 x 800
Ask165.01 x 1000
Day's range160.73 - 165.15
52-week range133.65 - 179.92
Avg. volume5,932,627
Market cap434.359B
Beta (5Y monthly)0.72
PE ratio (TTM)24.80
Earnings dateN/A
Forward dividend & yield4.24 (2.63%)
Ex-dividend date23 Aug 2021
1y target estN/A
  • CNW Group

    Eupraxia Pharmaceuticals Inc. Announces Appointment of Bruce Cousins as President & CFO

    Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a Phase 2 clinical-stage biotechnology company with an innovative drug delivery technology platform, today announced that it has appointed industry veteran Bruce Cousins as the Company's new President and Chief Financial Officer.

  • CNW Group

    Johnson & Johnson Announces Advance Purchase Agreement with the African Vaccine Acquisition Trust for the Company's COVID-19 Vaccine Candidate

    Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) (the Company), has entered into an agreement with the African Vaccine Acquisition Trust (AVAT) to make available up to 220 million doses of its single-shot COVID-19 vaccine candidate to African Union's 55 member states with delivery beginning in the third quarter of 2021. AVAT also has the potential to order an additional 180 million doses, for a combined total of up to 400 million doses through 2022. The availability of the vaccine candidate is subject to its successful approval or authorization by the national regulatory authorities of AU member states.

  • CNW Group

    The Global Energy Association: Ten key ideas in energy

    MOSCOW, Dec. 14, 2020 /CNW/ -- The Global Energy Association presented its first annual report entitled "Ten breakthrough ideas in energy for the next 10 years.